Title : Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.

Pub. Date : 2019 Jun 5

PMID : 31165773






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In both EJ28Luc and LN18 carcinoma cells treatment with 213Bi-anti-EGFR-MAb triggered a significant increase in lactate/pyruvate ratios, as measured with hyperpolarized [1-13C]pyruvate. Pyruvic Acid epidermal growth factor receptor Homo sapiens
2 In both EJ28Luc and LN18 carcinoma cells treatment with 213Bi-anti-EGFR-MAb triggered a significant increase in lactate/pyruvate ratios, as measured with hyperpolarized [1-13C]pyruvate. Pyruvic Acid epidermal growth factor receptor Homo sapiens